Glaxo’s Former China Head Accused of Ordering Bribes

Chinese police handed a bribery case against GlaxoSmithKline Plc’s China unit to prosecutors, accusing a British executive of ordering employees to illegally pay doctors, hospitals and medical associations to boost sales.

Mark Reilly, a British national who previously led GSK’s China unit, allegedly helped set up and expand sales departments that offered the bribes, a Ministry of Public Security official said at a briefing in Beijing today, declining to identify himself. Glaxo in an e-mailed statement said it will continue to fully co-operate with the authorities.